MADISON HEIGHTS, Mich., May 15, 2018 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, today announced the launch of InfuSystem Mobile, its innovative infusion patient safety app for smartphones and tablets. InfuSystem Mobile will seamlessly connect patients with InfuSystem's world-class suite of safety products, infusion expertise, and team of registered nurses who are available 24/7. As part of the launch, InfuSystem Mobile will be featured at the Oncology Nursing Society ("ONS") 43rd Annual Congress May 17-20, 2018 in Washington, D.C. The conference will be held at the Walter E. Washington Convention Center and is anticipated to draw 4,000 oncology nursing professionals.
InfuSystem Mobile provides patients with secure, two-way communication with the InfuSystem clinical support team of registered nurses, the latest infusion safety technology, and infusion therapy expertise in a convenient and easy-to-use app. Some of the innovative patient safety and convenience features of InfuSystem Mobile include:
- Automated Infusion Safety Alerts
- Convenient Patient Education Videos
- Secure Two-Way Communication
- Easy Paperless Form Submission
- Family Member Support
Richard DiIorio, chief executive officer of InfuSystem, said, "We are very excited about the launch of InfuSystem Mobile, our innovative new patient safety app that puts infusion safety right in the hands of our patients. InfuSystem Mobile will allow us to engage our patients directly. The app will connect our patients with the registered nurses on our world-class clinical support team and can reach out to them with safety alerts, infusion education, and more…all on a 24/7/365 basis. We believe this app represents an important step forward that will enable oncology patients to more effectively manage their treatment, whether they're at home or on-the-go, leading to a better outcome and an increase in quality of life."
The InfuSystem Mobile is available today for smartphones and tablets in the Apple App Store. For more information please go to www.infusystem.com/mobile.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Georgia and Ontario, Canada. The Company's stock is traded on the NYSE American under the symbol INFU.
Statements made in this press release that are not historical facts are considered to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," "strategy," "future," "likely," variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements include statements relating to future actions, business plans, objectives and prospects, future operating or financial performance, including the preliminary financial results contained in this press release. In connection with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, the Company is identifying certain factors that could cause actual results to differ, perhaps materially, from those indicated by these forward-looking statements. Those factors, risks and uncertainties include, but are not limited to, the potential changes in overall healthcare reimbursement, including Centers for Medicaid and Medicare Services ("CMS") competitive bidding and fee schedule reductions, sequestration, concentration of customers, increased focus on early detection of cancer, competitive treatments, dependency on Medicare Supplier Number, availability of chemotherapy drugs, global financial conditions, changes and enforcement of state and federal laws, natural forces, competition, dependency on suppliers, risks in acquisitions & joint ventures, U.S. Healthcare Reform, relationships with healthcare professionals and organizations, technological changes related to infusion therapy, the Company's ability to implement information technology improvements and to respond to technological changes, dependency on websites and intellectual property, the ability of the Company to successfully integrate acquired businesses, dependency on key personnel, dependency on banking relations and the ability to comply with Credit Facility covenants, and other risks associated with its common stock, as well as any litigation to which the Company may be involved in from time to time; and other risk factors as discussed in the Company's annual report on Form 10-K for the year ended December 31, 2017 and in other filings made by the Company from time to time with the Securities and Exchange Commission, including its quarterly reports on Form 10-Q. Our annual report on Form 10-K is available on the SEC's EDGAR website at www.sec.gov, and a copy may also be obtained by contacting the Company. All forward-looking statements made in this press release speak only as of the date hereof. We do not intend, and do not undertake any obligation, to update any forward-looking statements to reflect future events or circumstances after the date of such statements, except as required by law.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
Joe Dorame, Joe Diaz & Robert Blum
Lytham Partners, LLC
SOURCE InfuSystem Holdings, Inc.